Join Our Team
Contact Us
Company
Our Purpose
Company History
Leadership Team
Board of Directors
Partnership Opportunities
Corporate Compliance
Exhalation
Delivery Systems
Liquid Delivery
Powder Delivery Device
Anatomy of the Nasal Passages
Nasal Delivery Challenges
Therapeutic
Areas
Products
XHANCE
®
ONZETRA
®
Xsail
®
Research &
Development
XHANCE
®
– Future Development
Partnerships
Investors
News & Events
Stock Information
Corporate Governance
SEC Filings
Investor Resources
News &
Media
Scientific
Communications
Peer-Reviewed Journal Publications
OPN-375
December 22, 2014
Optinose’s late-stage candidate for treating nasal polyps.
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset
